Global Technologies, Ltd.

What they do

Global Technologies, Ltd operates through wholly owned subsidiaries. Primecare Supply, LLC, formed in Wyoming on October 22, 2024 and launched in May 2025, is a B2B procurement business that uses the proprietary Sinq Ops software platform to connect licensed 503B pharmaceutical manufacturers with licensed medical clinics in the United States, earning transaction-based revenue through direct clinic relationships and reseller partners. GTLL Advisory Group, LLC (trade name GloWell Advisors), formed May 20, 2025, is a consulting and advisory platform for medical spas, wellness clinics, and professional service practices; it did not commence financial operations in fiscal 2025 and expects to begin generating revenue in fiscal 2026. A third subsidiary, 10 Fold Services, LLC, formed November 22, 2023, is a health-and-wellness consulting and procurement agency.

Revenue drivers

• Primecare Supply (Sinq Ops procurement platform) — Earns per-transaction revenue from connecting licensed 503B manufacturers with licensed medical clinics via direct-to-clinic and reseller channels; the company describes it as a core growth engine, and it was the source of operations during the nine months ended March 31, 2026, as the business shifted from a prior wholesale/reseller model to direct-to-clinic procurement.
• GTLL Advisory Group (GloWell Advisors) — Intended to provide business transformation, data-driven consulting, and operational optimization to medical spas, wellness clinics, and professional service practices; it had no financial operations in fiscal 2025 and management expects revenue to begin in fiscal 2026.
• 10 Fold Services, LLC — A strategic consulting and procurement agency for health and wellness companies, using an automation-first approach for go-to-market planning and execution; the 10-K excerpt describing it is truncated, and no separate revenue for this subsidiary is given in the provided data.

Recent performance

Annual revenue rose from $15,000 in 2021 to $124,506 in 2022, $17,000 in 2023, approximately $1.1 million in 2024, and approximately $3.1 million in 2025. Net income was negative in 2021-2023, positive at $265,421 in 2024, and negative at -$342,681 in 2025. Operating cash flow was negative from 2021 through 2024 and turned positive at $354,823 in 2025. Recent quarterly revenue was $550,556 for the quarter ended June 30, 2025, $195,325 for September 30, 2025, $345,968 for December 31, 2025, and $101,529 for March 31, 2026. As of March 31, 2026, total assets were $42,399, total liabilities were $1.1 million, shareholder equity was -$1.1 million, and cash and equivalents were $38,178.

Strategy

Management states its strategy is to concentrate capital, management attention, and public-company infrastructure around subsidiaries that can produce measurable revenue, improve operating leverage, and create long-term enterprise value. At Primecare Supply, the stated priority during the nine months ended March 31, 2026 was transitioning from the prior wholesale/reseller revenue model toward a direct-to-clinic procurement platform to improve revenue quality, diversify supplier relationships, and increase ownership of clinic relationships and data. The company has continued expanding clinic outreach, supplier relationships, reseller channels, and use of the Sinq Ops portal. Management expects GTLL Advisory to commence revenue-generating operations in fiscal year 2026 as part of an expanding health-technology and advisory services portfolio.

Risks

• Going-concern doubt and accumulated deficit — As of June 30, 2025, the company had an accumulated deficit of $167,555,637 and stockholders' deficiency of $1,153,279, and its registered independent public accountants included an explanatory paragraph in their report on the fiscal 2025 and 2024 financial statements stating substantial doubt about the ability to continue as a going concern.
• Insufficient financial resources — The company states it has no sources of income at this time and no existing cash balances to meet ongoing operating expenses, and that in the short term it will be unable to meet ongoing operating expenses unless it raises additional debt and/or equity.
• Dilution or increased financial risk from future financings — The company states that if it cannot scale operations and achieve profitability, it may need additional equity or debt financing, which could dilute existing shareholders or increase its financial risk.
• Early-stage subsidiary execution — GTLL Advisory did not commence financial operations in fiscal 2025 and only expects to begin generating revenue in fiscal 2026, and Primecare Supply is transitioning from its prior wholesale/reseller revenue model to a direct-to-clinic model, so there is no assurance these expansions will generate sufficient near-term revenue.

Outlook

Management expects GTLL Advisory to commence revenue-generating operations in fiscal year 2026 as part of an expanding health-technology and advisory services portfolio. Primecare Supply is continuing its transition from a wholesale/reseller model to a direct-to-clinic procurement platform and expanding clinic outreach, supplier relationships, and use of the Sinq Ops portal. The company states that future losses are likely until sustained revenue growth is achieved, and that without scaling and profitability it may need additional equity or debt financing.